Use of Busulfan as Conditioning Agent for a Second Stem Cell Transplant

PHASE1CompletedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

September 23, 2004

Primary Completion Date

April 6, 2010

Study Completion Date

April 6, 2010

Conditions
Granulomatous DiseaseChronic
Interventions
DRUG

Busulfan

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00092937 - Use of Busulfan as Conditioning Agent for a Second Stem Cell Transplant | Biotech Hunter | Biotech Hunter